Hormone Therapy News

Puberty suppression and gender-affirming HT are not complicated treatments, meaning it does not necessarily require training in pediatric endocrinology.

For care with nonbinary children, there are no guidelines, there is very little experience, and all the knowledge we have is anecdotal. There is also not enough research.

In a little more than a decade, access to gender-affirming care for minors has increased greatly across the U.S.

Data on how stigmatization stress responses and gender-affirming hormone therapies may impact the heart health of transgender and gender-diverse individuals are lacking, researchers reported.

Testosterone deficiency — defined by the American Urological Association as a testosterone level of 300 ng/dL or fewer — occurs in as many as 39% of middle-aged and older U.S. men, data in Translational Andrology and Urology show.

Physicians and medical students at the AMA’s House of Delegates meeting voted to expand the association’s opposition to restrictions on transgender medical care.

Tamoxifen and steroidal aromatase inhibitor use among women with breast cancer was associated with a significantly lower risk for Alzheimer’s disease, a retrospective cohort study showed.

Transgender adults were more likely to report better mental health outcomes after having gender-affirming surgery compared with those who wish to have surgery, but have yet to undergo a procedure, according to study data.

Marginalization and stigma are directly related to poor physical and mental health outcomes, according to a speaker at the ACP Internal Medicine Meeting, held virtually.

Hormonal therapies for the treatment of breast and prostate cancers may improve survival among patients with cancer, but also may confer poor CV outcomes among survivors.